Clinical trial
Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer
NCT01349959
Study timeline
Study start (actual)2011-08-15Date precision: day
Registry last updated2025-04-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Male Breast Carcinomaunresolved
Recurrent Breast Carcinomaunresolved
Stage IIIC Breast Cancer AJCC v7unresolved
Stage IV Breast Cancer AJCC v6 and v7unresolved
Triple-Negative Breast Carcinomaunresolved
Interventions
AzacitidineDRUG · verified · RxNorm: azacitidine
EntinostatDRUG
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01349959 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.